ES2691529T3 - Animales con dipeptidil peptidasa iv (dpp4) humanizada - Google Patents
Animales con dipeptidil peptidasa iv (dpp4) humanizada Download PDFInfo
- Publication number
- ES2691529T3 ES2691529T3 ES15727832T ES15727832T ES2691529T3 ES 2691529 T3 ES2691529 T3 ES 2691529T3 ES 15727832 T ES15727832 T ES 15727832T ES 15727832 T ES15727832 T ES 15727832T ES 2691529 T3 ES2691529 T3 ES 2691529T3
- Authority
- ES
- Spain
- Prior art keywords
- dpp4
- rodent
- animals
- dipeptidyl peptidase
- dpp4 gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101150093210 DPP4 gene Proteins 0.000 title abstract 6
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 title 1
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 title 1
- 241001465754 Metazoa Species 0.000 title 1
- 241000283984 Rodentia Species 0.000 abstract 6
- 108700024394 Exon Proteins 0.000 abstract 2
- 241000711573 Coronaviridae Species 0.000 abstract 1
- 101100332180 Homo sapiens DPP4 gene Proteins 0.000 abstract 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/14—Dipeptidyl-peptidases and tripeptidyl-peptidases (3.4.14)
- C12Y304/14005—Dipeptidyl-peptidase IV (3.4.14.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462005476P | 2014-05-30 | 2014-05-30 | |
| US201462051626P | 2014-09-17 | 2014-09-17 | |
| US201462072692P | 2014-10-30 | 2014-10-30 | |
| PCT/US2015/033024 WO2015184164A1 (en) | 2014-05-30 | 2015-05-28 | Humanized dipeptidyl peptidase iv (dpp4) animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2691529T3 true ES2691529T3 (es) | 2018-11-27 |
Family
ID=53366330
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES15727832T Active ES2691529T3 (es) | 2014-05-30 | 2015-05-28 | Animales con dipeptidil peptidasa iv (dpp4) humanizada |
| ES18173004T Active ES2877275T3 (es) | 2014-05-30 | 2015-05-28 | Animales con dipeptidil peptidasa IV (DPP4) humanizada |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18173004T Active ES2877275T3 (es) | 2014-05-30 | 2015-05-28 | Animales con dipeptidil peptidasa IV (DPP4) humanizada |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US9497945B2 (enExample) |
| EP (2) | EP2993977B1 (enExample) |
| JP (2) | JP6212659B2 (enExample) |
| KR (1) | KR101737432B1 (enExample) |
| CN (2) | CN111118047B (enExample) |
| AU (1) | AU2015266841C1 (enExample) |
| BR (1) | BR112016026245A2 (enExample) |
| CA (1) | CA2947899C (enExample) |
| ES (2) | ES2691529T3 (enExample) |
| IL (1) | IL248702B (enExample) |
| MX (2) | MX387036B (enExample) |
| NZ (1) | NZ726355A (enExample) |
| PH (1) | PH12016502170A1 (enExample) |
| RU (1) | RU2648166C1 (enExample) |
| SG (1) | SG11201609154TA (enExample) |
| WO (1) | WO2015184164A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3701B1 (ar) * | 2014-05-23 | 2021-01-31 | Regeneron Pharma | مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي |
| ES2691529T3 (es) | 2014-05-30 | 2018-11-27 | Regeneron Pharmaceuticals, Inc. | Animales con dipeptidil peptidasa iv (dpp4) humanizada |
| WO2019067875A1 (en) * | 2017-09-29 | 2019-04-04 | Regeneron Pharmaceuticals, Inc. | NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS AND METHODS OF USE |
| CN109022489B (zh) * | 2018-08-09 | 2023-03-31 | 中国食品药品检定研究院 | 人dpp4基因敲入的小鼠模型、其产生方法和用途 |
| BR112021016173A2 (pt) | 2019-02-22 | 2021-11-03 | Regeneron Pharma | Roedor geneticamente modificado, métodos de produção de um roedor geneticamente modificado e de produção de um anticorpo anti-nav1.7, célula ou tecido isolado de roedor, linhagem celular imortalizada, embrião de roedor, construto de ácido nucleico de direcionamento, e, hibridoma |
| WO2021154791A1 (en) * | 2020-01-28 | 2021-08-05 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized pnpla3 locus and methods of use |
| KR102207249B1 (ko) * | 2020-02-28 | 2021-01-25 | 대한민국(관리청: 특허청장, 승계청: 질병관리청장) | 한국형 중동호흡기증후군 코로나바이러스 감염에 감수성을 가지는 인간 dpp4 유전자를 전신에 발현하는 형질전환마우스와 이의 용도 |
| KR102243416B1 (ko) * | 2020-02-28 | 2021-04-22 | 대한민국(질병관리청장) | 한국형 중동호흡기증후군 코로나바이러스 감염에 감수성을 가지는 인간 dpp4 유전자를 폐 조직 특이적으로 발현하는 형질전환마우스와 이의 용도 |
| CN113355325B (zh) * | 2020-03-06 | 2023-07-14 | 中国科学院广州生物医药与健康研究院 | 人源化ace2基因改造小鼠胚胎干细胞模型制备方法及应用 |
| EP4171215A2 (en) * | 2020-06-26 | 2023-05-03 | Regeneron Pharmaceuticals, Inc. | Non-human animals comprising a humanized ace2 locus |
| WO2024124111A1 (en) * | 2022-12-08 | 2024-06-13 | The Regents Of The University Of California | Multimeric protein complexes for neutralization of viral pathogens in diagnostic, prophylactic, and therapeutic applications |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6368604B1 (en) * | 1997-09-26 | 2002-04-09 | University Of Maryland Biotechnology Institute | Non-pyrogenic derivatives of lipid A |
| WO2002006633A1 (en) | 2000-07-18 | 2002-01-24 | The Charles Machine Works, Inc. | Remote control for a drilling machine |
| US20050144655A1 (en) | 2000-10-31 | 2005-06-30 | Economides Aris N. | Methods of modifying eukaryotic cells |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6596541B2 (en) * | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2004104216A2 (en) * | 2003-05-21 | 2004-12-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| EP1802193B1 (en) | 2004-10-19 | 2014-04-30 | Regeneron Pharmaceuticals, Inc. | Method for generating a mouse homozygous for a genetic modification |
| US20060272038A1 (en) | 2005-05-27 | 2006-11-30 | Michael De Vivo | Transgenic Alzheimer's mouse model vectors and uses thereof |
| ES2497496T3 (es) * | 2006-12-22 | 2014-09-23 | Genentech, Inc. | Ratones transgénicos que expresan VEGF humanizado |
| WO2010110914A2 (en) * | 2009-03-27 | 2010-09-30 | Zirus, Inc. | Mammalian genes involved in infection |
| EP3498730B1 (en) | 2009-12-21 | 2026-01-28 | Regeneron Pharmaceuticals, Inc. | Humanized fc gamma r mice |
| CN105950654B (zh) * | 2010-11-27 | 2020-03-20 | 朱坚 | 一种人源化的转基因动物 |
| PT4233537T (pt) * | 2011-02-15 | 2025-09-08 | Regeneron Pharma | Ratinhos humanizados para m-csf e utilizações dos mesmos |
| SI2818478T1 (sl) * | 2011-10-28 | 2017-07-31 | Regeneron Pharmaceuticals, Inc. | Humanizirani il-6 in receptor il-6 |
| EP2898067B1 (en) * | 2012-09-23 | 2020-01-15 | Erasmus University Medical Center Rotterdam | Human betacoronavirus lineage c and identification of n-terminal dipeptidyl peptidase as its virus receptor |
| MX2015010841A (es) | 2013-02-20 | 2016-05-09 | Regeneron Pharma | Modificacion genetica de ratas. |
| DK3456831T3 (da) | 2013-04-16 | 2021-09-06 | Regeneron Pharma | Målrettet modifikation af rottegenom |
| CN103554235B (zh) * | 2013-06-17 | 2015-06-24 | 清华大学 | MERS-CoV病毒膜蛋白中的RBD片段及其编码基因和应用 |
| CN103724406A (zh) * | 2013-11-20 | 2014-04-16 | 中国疾病预防控制中心病毒病预防控制所 | 一种具有中和活性的MERS-CoV合成肽疫苗及其应用 |
| MX388127B (es) * | 2013-12-11 | 2025-03-19 | Regeneron Pharma | Metodos y composiciones para la modificacion dirigida de un genoma. |
| ES2691529T3 (es) | 2014-05-30 | 2018-11-27 | Regeneron Pharmaceuticals, Inc. | Animales con dipeptidil peptidasa iv (dpp4) humanizada |
-
2015
- 2015-05-28 ES ES15727832T patent/ES2691529T3/es active Active
- 2015-05-28 ES ES18173004T patent/ES2877275T3/es active Active
- 2015-05-28 EP EP15727832.6A patent/EP2993977B1/en active Active
- 2015-05-28 MX MX2020004803A patent/MX387036B/es unknown
- 2015-05-28 CN CN202010059426.XA patent/CN111118047B/zh active Active
- 2015-05-28 WO PCT/US2015/033024 patent/WO2015184164A1/en not_active Ceased
- 2015-05-28 JP JP2016566982A patent/JP6212659B2/ja active Active
- 2015-05-28 AU AU2015266841A patent/AU2015266841C1/en active Active
- 2015-05-28 US US14/723,855 patent/US9497945B2/en active Active
- 2015-05-28 BR BR112016026245A patent/BR112016026245A2/pt not_active IP Right Cessation
- 2015-05-28 EP EP18173004.5A patent/EP3381279B1/en active Active
- 2015-05-28 CN CN201580027887.6A patent/CN106413394B/zh active Active
- 2015-05-28 SG SG11201609154TA patent/SG11201609154TA/en unknown
- 2015-05-28 CA CA2947899A patent/CA2947899C/en active Active
- 2015-05-28 MX MX2016015609A patent/MX373055B/es active IP Right Grant
- 2015-05-28 RU RU2016150679A patent/RU2648166C1/ru active
- 2015-05-28 KR KR1020167031766A patent/KR101737432B1/ko not_active Expired - Fee Related
- 2015-05-28 NZ NZ726355A patent/NZ726355A/en not_active IP Right Cessation
- 2015-08-12 US US14/824,475 patent/US9532555B2/en active Active
-
2016
- 2016-10-17 US US15/295,955 patent/US10212923B2/en active Active
- 2016-11-02 IL IL248702A patent/IL248702B/en active IP Right Grant
- 2016-11-02 PH PH12016502170A patent/PH12016502170A1/en unknown
-
2017
- 2017-09-15 JP JP2017177761A patent/JP6636486B2/ja active Active
-
2019
- 2019-01-03 US US16/239,028 patent/US11013220B2/en active Active
-
2021
- 2021-04-21 US US17/236,083 patent/US12256720B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3558188A4 (en) | COMPOSED Wound Bandage With Charcoal | |
| EA201691911A1 (ru) | Быстродействующие композиции инсулина | |
| IL249837B (en) | Inhaler for pulmonary delivery of active agents | |
| DOP2017000124A (es) | Agonistas parciales del receptor de insulina | |
| DK3212208T3 (da) | Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet | |
| MX2022007894A (es) | Receptores de antigeno quimerico condicionalmente activos para celulas t modificadas. | |
| CL2016003075A1 (es) | Composición para tratar diabetes, que contiene un conjugado de análogo de insulina de acción prolongada y un conjugado de péptido insulinotrópico de acción prolongada | |
| CL2016001889A1 (es) | (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1. | |
| CL2017003096A1 (es) | Vectores virales adenoasociados para el tratamiento de mucopolisacaridosis | |
| GT201600233A (es) | Compuestos y composiciones como agonistas del receptor tipo toll 7 | |
| ECSP17010156A (es) | Compuestos aminopirimidinilo como inhibidores jak | |
| DK3841877T5 (da) | Genetisk modificeret mus, der eksprimerer human EPO | |
| MX380866B (es) | Composiciones y métodos para modular la expresión del factor b del complemento. | |
| CL2016003246A1 (es) | Compuestos de dihidroisoquinolinona sustituida | |
| DOP2015000288A (es) | Composiciones de arni de serpina1 y sus métodos de uso. | |
| SI3126499T1 (sl) | Sestave za moduliranje izražanja SOD-1 | |
| PH12016501441A1 (en) | Chimeric alkaline phosphate-like proteins | |
| HUE042628T2 (hu) | Mono- vagy diszubsztituált indolok mint dengue vírus replikáció inhibitorok | |
| BR112016017402A2 (pt) | fusões anti-pcsk9~glp-1 e métodos para uso | |
| EA201791508A1 (ru) | Способы трансдифференцировки и способы их использования | |
| EP3360208A4 (en) | SINGLE-STEP LASER AMPLIFIER WITH PULLEY PUMPS | |
| BR112016024539A8 (pt) | Combinador óptico ativo para rede catv | |
| MX2016015609A (es) | Animales con dipeptidil peptidasa iv (dpp4) humanizada. | |
| MX387661B (es) | Composiciones y métodos para el tratamiento de lesiones cutáneas precancerosas. | |
| EP3190886C0 (en) | COMPOSITIONS FOR USE IN THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME |